Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP726477.RADaoGomYFhByF_gW4bL1lalJOgeeTxmneqEsGCdKSRSU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP726477.RADaoGomYFhByF_gW4bL1lalJOgeeTxmneqEsGCdKSRSU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP726477.RADaoGomYFhByF_gW4bL1lalJOgeeTxmneqEsGCdKSRSU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP726477.RADaoGomYFhByF_gW4bL1lalJOgeeTxmneqEsGCdKSRSU130_provenance.
- NP726477.RADaoGomYFhByF_gW4bL1lalJOgeeTxmneqEsGCdKSRSU130_assertion description "[In addition, we found that p16 (INK4a) is also downregulated in immortal cells and that coexpression of CREG1 and p16 (INK4a) , an inhibitor of CDK4/6 and Rb phosphorylation, has a greater effect than either CREG1 and p16 (INK4a) alone to reduce cell growth, induce cell cycle arrest and cellular senescence in immortal LFS fibroblasts, osteosarcoma and fibrosarcoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP726477.RADaoGomYFhByF_gW4bL1lalJOgeeTxmneqEsGCdKSRSU130_provenance.
- NP726477.RADaoGomYFhByF_gW4bL1lalJOgeeTxmneqEsGCdKSRSU130_assertion evidence source_evidence_literature NP726477.RADaoGomYFhByF_gW4bL1lalJOgeeTxmneqEsGCdKSRSU130_provenance.
- NP726477.RADaoGomYFhByF_gW4bL1lalJOgeeTxmneqEsGCdKSRSU130_assertion SIO_000772 21263217 NP726477.RADaoGomYFhByF_gW4bL1lalJOgeeTxmneqEsGCdKSRSU130_provenance.
- NP726477.RADaoGomYFhByF_gW4bL1lalJOgeeTxmneqEsGCdKSRSU130_assertion wasDerivedFrom befree-20140225 NP726477.RADaoGomYFhByF_gW4bL1lalJOgeeTxmneqEsGCdKSRSU130_provenance.
- NP726477.RADaoGomYFhByF_gW4bL1lalJOgeeTxmneqEsGCdKSRSU130_assertion wasGeneratedBy ECO_0000203 NP726477.RADaoGomYFhByF_gW4bL1lalJOgeeTxmneqEsGCdKSRSU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP726477.RADaoGomYFhByF_gW4bL1lalJOgeeTxmneqEsGCdKSRSU130_provenance.